Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancerN. Lynn Henry, David A. Flockhart, Anne Nguyen et al.|Breast Cancer Research and Treatment|2013Cited by 64
Predictors of recovery of ovarian function during aromatase inhibitor therapyN. Lynn Henry, Daniel F. Hayes, Rong Xia et al.|Annals of Oncology|2013Cited by 46
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancerDaniel L. Hertz, James M. Rae, N. Lynn Henry et al.|The Pharmacogenomics Journal|2016Cited by 25